Presence of antibodies to replication protein A in some patients with systemic lupus erythematosus (SLE)

Clin Exp Immunol. 1996 Jan;103(1):74-6. doi: 10.1046/j.1365-2249.1996.00919.x.

Abstract

Presence of antibodies directed against replication protein A (RPA), a DNA binding protein complex composed of three subunits (RPA-70, RPA-32 and RPA-14) was investigated among patients with SLE and other autoimmune diseases using immunoblot analysis to RPA-70 and RPA-32 recombinant proteins. Anti-RPA antibodies were found in two out of 108 sera from SLE patients, one of them showing reactivity against RPA-32 and RPA-70 and the other reacting only against RPA-32. Sera from 108 patients with other autoimmune disorders as well as from 42 healthy control individuals were negative. Thus, the frequency of these antibodies in SLE is estimated to be 2-3%. The study demonstrates that RPA is one target more of the wide array of autoantigens that elicit an immune response in SLE. The presence of anti-RPA autoantibodies seems to be circumscribed to a small number of patients with SLE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Autoantibodies / blood*
  • DNA-Binding Proteins / immunology*
  • Female
  • HeLa Cells
  • Humans
  • Immunoblotting
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / immunology*
  • Male
  • Middle Aged
  • Replication Protein A

Substances

  • Autoantibodies
  • DNA-Binding Proteins
  • RPA1 protein, human
  • Replication Protein A